Unité de Valorisation de la Recherche et Transfert de Technologie VR2T
One more step toward our strategic partnership with one of the most active biotech research centers in Tunisia: the Centre de Biotechnologie de Borj Cédria – CBBC. We are thrilled to announce our collaboration with Besma Sioud and the technology transfer unit, Unité de valorisation de la recherche et transfert de technologie (VR2T), for connecting the Chitelix team with a brilliant panel of researchers.
We extend our gratitude to the following distinguished professors who will be working closely with us:
- Professor Olfa Tabben – Director of the Laboratory of Molecular Physiology of Plants (LPMP)
- Professor Asma Ben Salem – Director of the Laboratory of Bioactive Substances (LSBA)
- Professor Saidani Moufida – Director of the Laboratory of Aromatic and Medicinal Plants (LPAM)
- Professor Mohsen Hanana – Laboratory of Extremophile Plants (LPE)
- Professor Nabil Ben Younes – Laboratory of Olive Tree Biotechnology , (LBO)
This collaboration marks a significant milestone in our pursuit of advancing biotechnology research and development. The CBBC is renowned for its cutting-edge research and expertise in various biotechnological fields. By partnering with such esteemed professionals, we aim to foster innovation and contribute to the growth of the biotech industry in Tunisia.
The CBBC’s commitment to excellence aligns perfectly with our own values and goals. We believe that by combining our resources and knowledge, we can make significant strides towards addressing global challenges in the field of biotechnology.
Through this partnership, we anticipate exciting opportunities for knowledge exchange, joint research projects, and technology transfer. The collaboration will enable us to leverage the CBBC’s state-of-the-art facilities and expertise, enhancing our research capabilities and accelerating the development of groundbreaking solutions.
We are confident that the collective efforts of our teams will yield remarkable results and contribute to the advancement of biotechnology not only in Tunisia but also on a global scale. Together, we can pave the way for innovative discoveries and contribute to the betterment of society.
As we embark on this journey, we express our gratitude once again to the CBBC, Besma Sioud, and the VR2T for their invaluable support in facilitating this partnership. We look forward to a fruitful collaboration and the positive impact it will have on the biotech landscape.
